CTE Sessions at EANM’10

EANM’10 – Mini Course III

October 10, 2010, 17:00 – 18:00
Clinical Dosimetry

Moderator: G. Testanera (Milan), M. Bardies (Nantes)

C. Chiesa (Milan):
Technical aspects of clinical dosimetry
M. Luster (Ulm):
Practical implementation of clinical dosimetry on radionuclide therapy for thyroid cancer and neuroendocrinal tumou

Educational objectives:

Upon completion of this session the attendee will be able to:

  1. Explain clinical dosimetry terminology, tasks and instrumentations.
  2. Give an overview on the more common procedures for clinical dosimetry.
  3. Focus on state of art for radionuclide therapy in thyroid cancer and neuroendocrinal tumours.
  4. Relate common practice in radionuclide therapy with clinical dosimetry procedures.
  5. Discuss how these procedures can be performed in clinical routine and in which way technologists can be involved.


Up to now radionuclide therapy has become a common and widely accepted clinical treatment for thyroid cancer and also for neuroendocrinal tumours. These practices are usually performed in Nuclear Medicine departments involving not only physicians and nurses but also physicists and technologists. Pre-therapeutic dosimetry and peri-therapeutic dosimetry are standard methods to assess patient-specific absorbed dose and are useful to tailor the therapeutic activity to be administered to every patient treated. Correct procedures on dosimetry may have a great influence in clinical approach and patient management.
The mini course will give an insight on how clinical dosimetry must be performed, which instruments are needed, which professional figures are involved and how it may change clinical approach. The talk will also focus on two main applications of radionuclide therapy in thyroid cancer and neuroendocrinal tumours, describing more common dosimetry procedures for these specific treatments.

Key Words:

clinical dosimetry, radionuclide therapy, thyroid cancer, neuroendocrinal tumours, technologists

This website uses cookies. Learn more